Shuttle Pharmaceuticals Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Shuttle Pharmaceuticals Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $6 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than almost all Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 96% of Healthcare companies in United States.
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-122.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 86% of Healthcare companies in United States.
Cash Cushion Ratio
+0%Cash, after subtracting all debt, equals 0% of its market value (net cash).
Lower than 66% of Healthcare companies in United States.
Tangible Assets Ratio
6%Of every $100 the company owns, $6 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than almost all Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 96% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Shuttle Pharmaceuticals Holdings, Inc. made a loss over the last year. Shuttle Pharmaceuticals Holdings, Inc. owes $0.72 for every $1 it owns. Shuttle Pharmaceuticals Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossShuttle Pharmaceuticals Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
6.56The share price is 6.56 times Shuttle Pharmaceuticals Holdings, Inc.'s book value per share, higher than 78% of Healthcare companies in United States.
Market cap
$22 MThe total market value of all of Shuttle Pharmaceuticals Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 81% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$3 MWhat Shuttle Pharmaceuticals Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
$0.70Net worth divided by the number of shares. The share price of $4.61 is 6.6 times this, which is the P/B above.
Return on equity (ROE)
-90.0%Shuttle Pharmaceuticals Holdings, Inc. lost 90.0% of its shareholders' money over the last year, lower than 68% of Healthcare companies in United States.
Owes vs Owns
0.72×Shuttle Pharmaceuticals Holdings, Inc. owes $0.72 for every $1 it owns (moderate), higher than 72% of Healthcare companies in United States.
Dividend yield
NoneShuttle Pharmaceuticals Holdings, Inc. does not currently pay a dividend.
Profit growth
LossShuttle Pharmaceuticals Holdings, Inc. made a loss in each of the last two years.
Interest cover
Not coveredShuttle Pharmaceuticals Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashShuttle Pharmaceuticals Holdings, Inc. held $0 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Shuttle Pharmaceuticals Holdings, Inc.: $22 M ÷ $3 M (31 Mar 2026) = 6.6.
What is Shuttle Pharmaceuticals Holdings, Inc.'s return on equity?
Shuttle Pharmaceuticals Holdings, Inc. lost 90.0% of its shareholders' money over the last year, lower than 68% of Healthcare companies in United States.
How much does Shuttle Pharmaceuticals Holdings, Inc. owe compared with what it owns?
Shuttle Pharmaceuticals Holdings, Inc. owes $0.72 for every $1 it owns (moderate), higher than 72% of Healthcare companies in United States.
Does Shuttle Pharmaceuticals Holdings, Inc. pay a dividend?
No. Shuttle Pharmaceuticals Holdings, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.